 EMERYVILLE, Calif.--BUSINESS WIRE--Lucira Health, Inc. Nasdaq: LHDX, a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that Health Canada issued an Authorization with Conditions for the LUCIRATM CHECK IT COVID-19 test kit. The Authorization with Conditions was issued by Health Canada under the Interim Order IO Respecting the Importation and Sale of Medical Devices for Use in Relation 